Moxetumomab pasudotox-Third line in Hairy cell leukemia

xlomafota13 shared this article with you from Inoreader Moxetumomab pasudotox-Third line in Hairy cell leukemia Via Association française pour l'étude du cancer Bull Cancer. 2021 Nov 11:S0007-4551(21)00378-7. doi: 10.1016/j.bulcan.2021.07.011. Online ahead of print. NO ABSTRACT PMID:34776118 | DOI:10.1016/j.bulcan.2021.07.011 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.